Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 76% ± 22% | |
peripheral blood | 19 studies | 88% ± 14% | |
intestine | 14 studies | 74% ± 25% | |
brain | 12 studies | 44% ± 18% | |
eye | 10 studies | 56% ± 18% | |
kidney | 8 studies | 78% ± 19% | |
liver | 7 studies | 63% ± 25% | |
bone marrow | 6 studies | 86% ± 11% | |
pancreas | 5 studies | 87% ± 18% | |
uterus | 5 studies | 89% ± 15% | |
lymph node | 4 studies | 96% ± 2% | |
placenta | 4 studies | 87% ± 16% | |
adipose | 4 studies | 52% ± 25% | |
esophagus | 4 studies | 62% ± 31% | |
prostate | 4 studies | 88% ± 20% | |
breast | 4 studies | 94% ± 4% | |
heart | 3 studies | 47% ± 15% | |
skin | 3 studies | 81% ± 18% | |
stomach | 3 studies | 54% ± 31% | |
thymus | 3 studies | 82% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 58405.71 | 21 / 21 | 100% | 809.27 | 504 / 504 |
esophagus | 100% | 49885.92 | 1445 / 1445 | 100% | 467.81 | 183 / 183 |
ovary | 100% | 131350.69 | 180 / 180 | 100% | 1183.08 | 430 / 430 |
pancreas | 100% | 53824.63 | 328 / 328 | 100% | 668.98 | 178 / 178 |
prostate | 100% | 51381.74 | 245 / 245 | 100% | 1194.68 | 502 / 502 |
stomach | 100% | 40051.35 | 359 / 359 | 100% | 727.41 | 286 / 286 |
thymus | 100% | 48294.89 | 653 / 653 | 100% | 1187.56 | 605 / 605 |
uterus | 100% | 70621.02 | 170 / 170 | 100% | 887.14 | 459 / 459 |
kidney | 100% | 34332.80 | 89 / 89 | 100% | 661.56 | 900 / 901 |
lung | 100% | 36315.80 | 577 / 578 | 100% | 710.79 | 1155 / 1155 |
intestine | 100% | 52940.06 | 966 / 966 | 100% | 901.66 | 526 / 527 |
breast | 100% | 60985.64 | 459 / 459 | 100% | 761.47 | 1115 / 1118 |
skin | 100% | 58615.19 | 1809 / 1809 | 99% | 723.31 | 466 / 472 |
brain | 98% | 18823.73 | 2597 / 2642 | 100% | 622.36 | 705 / 705 |
adrenal gland | 100% | 43335.04 | 258 / 258 | 97% | 472.88 | 224 / 230 |
liver | 96% | 15817.05 | 218 / 226 | 99% | 492.60 | 402 / 406 |
adipose | 100% | 54684.01 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 48384.93 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 1457.32 | 29 / 29 |
spleen | 100% | 39514.98 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 724.65 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 351.31 | 1 / 1 |
muscle | 99% | 28421.68 | 796 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 1107.66 | 79 / 80 |
heart | 95% | 25033.61 | 821 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 32364.12 | 749 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000059 | Biological process | negative regulation of ubiquitin-dependent protein catabolic process |
GO_0006412 | Biological process | translation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0000027 | Biological process | ribosomal large subunit assembly |
GO_2000435 | Biological process | negative regulation of protein neddylation |
GO_0042273 | Biological process | ribosomal large subunit biogenesis |
GO_0050821 | Biological process | protein stabilization |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_1904667 | Biological process | negative regulation of ubiquitin protein ligase activity |
GO_0045727 | Biological process | positive regulation of translation |
GO_0006364 | Biological process | rRNA processing |
GO_0002181 | Biological process | cytoplasmic translation |
GO_0005730 | Cellular component | nucleolus |
GO_0022626 | Cellular component | cytosolic ribosome |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0022625 | Cellular component | cytosolic large ribosomal subunit |
GO_0005925 | Cellular component | focal adhesion |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005634 | Cellular component | nucleus |
GO_1990948 | Molecular function | ubiquitin ligase inhibitor activity |
GO_0048027 | Molecular function | mRNA 5'-UTR binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0008097 | Molecular function | 5S rRNA binding |
GO_0003735 | Molecular function | structural constituent of ribosome |
GO_0003723 | Molecular function | RNA binding |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RPL5 |
Protein name | Ribosomal protein L5 Large ribosomal subunit protein uL18 (60S ribosomal protein L5) RPL5 protein (Ribosomal protein L5, isoform CRA_a) |
Synonyms | MSTP030 hCG_2028912 |
Description | FUNCTION: Component of the ribosome, a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell. The small ribosomal subunit (SSU) binds messenger RNAs (mRNAs) and translates the encoded message by selecting cognate aminoacyl-transfer RNA (tRNA) molecules. The large subunit (LSU) contains the ribosomal catalytic site termed the peptidyl transferase center (PTC), which catalyzes the formation of peptide bonds, thereby polymerizing the amino acids delivered by tRNAs into a polypeptide chain. The nascent polypeptides leave the ribosome through a tunnel in the LSU and interact with protein factors that function in enzymatic processing, targeting, and the membrane insertion of nascent chains at the exit of the ribosomal tunnel. As part of the 5S RNP/5S ribonucleoprotein particle it is an essential component of the LSU, required for its formation and the maturation of rRNAs . It also couples ribosome biogenesis to p53/TP53 activation. As part of the 5S RNP it accumulates in the nucleoplasm and inhibits MDM2, when ribosome biogenesis is perturbed, mediating the stabilization and the activation of TP53 . . |
Accessions | A0A2R8Y4A2 ENST00000370321.8 ENST00000645300.1 R4GNJ2 ENST00000470843.5 B3KTM6 A2RUM7 Q8WYP1 ENST00000645119.1 Q9BUV4 P46777 Q5T7N0 A0A2R8Y6J3 ENST00000315741.5 |